The fact that last year only three companies concluded contracts with the state company Montefarm for the procurement of medicines clearly shows that the monopoly in that area continues, according to the non-governmental organization (NGO) Action for Social Justice (ASP).
The ASP said that last year contracts with Montefarma for the supply of drugs and related medical supplies, worth 93,5 million euros, were signed by only three companies, two of which have as many as 75,7 million euros in contracts signed by the same owner from the Glossarij group.
As stated by that NGO, public records show that the total value of all concluded contracts for this type of public procurement is over 108 million euros, which means that the first three companies cover more than 86 percent of the market, while only two companies of the Glossary group cover about 70 percent. .
The ASP emphasized that the citizens of Montenegro have been paying for the most expensive medicines in the region for years.
"These data are a clear indication of the continuation of a heavy monopoly on the drug market, which was once established by the government of the Democratic Party of Socialists, and no government after it has moved a finger to change the harmful legal provisions in order to break the monopoly and protect citizens as consumers," they said from and NGOs.
According to them, the company Glosarij, which is officially backed by Branislav Martinović, received jobs worth over 65,3 million euros from Montefarma last year.
"And he is also the owner of the company Glosarij CD, which received jobs worth over 10,3 million euros," the ASP statement added.
It is stated that the Farmegra company, which, according to official records, is backed by the Belgrade company Evropa Lek Pharma, received over 17,7 million, which is over 16 percent of the market.
"The Medica company, which is currently backed by Veselin Vujović and Budimir Stanišić, who is the former director of Montefarma, has concluded contracts with the state public institution for pharmacies worth over five million euros," ASP said.
As they stated, the company Urion received jobs worth more than 2,2 million euros, Farmont more than 1,7 million, Medical Solutions more than 1,6 million, and Farmalab more than 1,3 million euros.
ASP said that another 11 companies received deals worth less than one million, and the total value of the deals concluded with them is around 2,5 million euros.
"Information is based on public records, and ASP takes them as reliable only if they are shown as such in those records," added the statement of that NGO.
Bonus video:
